Search results
Reneo Pharmaceuticals Inc (RPHM) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 6 months agoReneo Pharmaceuticals Inc (NASDAQ:RPHM) anticipates pivotal STRIDE study topline data in December 2023. Q3 2023 saw a net loss of $19.2 million, a deeper loss compared to Q3 2022's $13.0 million ...